Halsa Health Group Inc. entered into a share purchase agreement to acquire Élitis Pharma Inc. and Logistique Pharma Inc. from KDA Group Inc. (TSXV:KDA) for CAD 2.1 million on March 27, 2023. The Corporation expects to use the Purchase Price received at closing to repay a portion of its debts, for working capital and general expenses. The closing of the proposed transaction is subject to the satisfaction of certain conditions including the approval of the TSX Venture Exchange and the consent of KDA's creditors, Persistence Capital Partners II, L.P. and Private Debt Partners Senior Opportunities Fund LP.

The closing of the proposed transaction is expected to be held on or before April 14, 2023.